AnalystBook Research · Company Intelligence

AMREP CORP.

AXRNYSE

Built from AMREP CORP.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

AMREP revenue slipped, but net income and margins rose sharply, debt fell, and insiders bought nearly $878K.

The read at a glance✓ Audited against SEC data
  • Business mixLand development and home buildingNote
  • RevenueRevenue fell 3.3%Watch
  • ProfitNet income rose 90.1%OK
  • CashFree cash flow fell 5.8%Watch
  • Balance sheetDebt fell; equity rose 10.1%OK
  • Insiders16 buys / 0 sellsOK
  • AccountingAltman-Z, Beneish-M, and earnings-quality unavailableNote

Business

AMREP is a real-estate company with Land Development and Home Building segments, concentrated around land and home sales.

Where the revenue comes from

Fiscal 2026, as AMREP CORP. reports it. History and quarterly detail are in the app.

  • Land Development$29.2M
  • Homebuilding$23.6M

Leadership changes

From AMREP CORP.'s own filings, the day they're filed.

  • Timothy S. McNaney · director · appointmenteff. 2026-01-27
  • Adrienne M. Uleau · Chief Financial Officer · appointmenteff. 2025-07-17
  • Timothy McNaney · President · departure

Latest filings

  • 10-K · Annual report2026-07-24
  • 8-K · Company announcement2026-07-24
  • 8-K · Company announcement2026-07-14
  • 8-K · Company announcement2026-03-12
  • 10-Q · Quarterly report2026-03-12
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about AMREP CORP., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.